Similarly, the enrichment of HES6 and MYC motifs in brain-specific promoters provides mechanistic insights into neuroblastoma and glioblastoma pathogenesis as these factors are known to be dysregulated in aggressive brain cancers. The gene discussed is MYC; the disease is brain cancer.